The gonadotropins LH (Luteinizing Hormone) and FSH (Follicle-Stimulating Hormone) are glycoprotein hormones secreted by the anterior pituitary and represent the effector output of the hypothalamic-pituitary-gonadal axis. In reproductive physiology, they are the obligatory link between central signals and gonadal function, translating the temporal code of GnRH into steroidogenesis, gametogenesis and tissue remodeling in the ovary and testis. Their action cannot be reduced to a simple “stimulation” of the gonad: LH and FSH operate as two complementary signals which, by acting on distinct cell populations and on partially different signaling programs, coordinate the sequence of reproductive events and the maintenance of the gonadal phenotype over time.
From a systems physiology perspective, LH and FSH are an emblematic example of endocrine regulation in which biological meaning derives from the integration of pulsatility of the hypothalamic input, the decoding capacity of gonadotroph cells and the molecular quality of circulating forms. Pituitary production depends on a set of regulatory knobs that include the frequency and amplitude of GnRH pulses, modulation by activin, inhibin and follistatin, steroid feedback and metabolic factors, while peripheral efficacy is determined by the density and competence of gonadal receptors, desensitization dynamics and glycosylation microheterogeneity. As a result, LH and FSH are “informational” hormones, whose physiology is inseparable from the temporal dimension and molecular biology.
LH and FSH are produced by the gonadotroph cells of the pars distalis, a specialized pituitary phenotype that continuously integrates hypothalamic and peripheral signals to generate a high-precision output. Central control is exerted by GnRH, released in a pulsatile manner into the hypothalamic-pituitary portal system: this pulsatility is not an accessory detail, but the organizing principle that allows the system to differentially regulate the synthesis and secretion of LH and FSH. The gonadotroph cell responds not only to the presence of GnRH, but to its dynamics, translating different frequencies into distinct combinations of intracellular signals and transcriptional programs that modulate common subunits and specific beta subunits with different temporal patterns.
Decoding of the GnRH pulse occurs through the GnRH receptor (GnRHR) and a signaling network that includes activation of phospholipase pathways, calcium mobilization, kinase activation and regulation of immediate transcription factors. Within this framework, LH production is closely linked to the availability of secretory granules and to the capacity for regulated exocytosis synchronized with the pulse, whereas FSH production is strongly affected by transcriptional regulation of the beta subunit and by paracrine modulation by activin and inhibin. The result is that the axis can generate outputs synchronized with the hypothalamic signal for rapid events, and outputs more “integrated” over time for processes that require prolonged support.
A second level of control, crucial for functional specificity, is represented by the regulatory glycoproteins produced mainly by the gonad. Activin tends to promote FSH synthesis by enhancing transcriptional programs in the gonadotroph cell, whereas inhibin exerts selective control that limits FSH production without suppressing LH to the same extent. Follistatin, by binding activin, further modulates the system, creating a fine regulatory axis that allows the gonadal compartment to directly influence pituitary output. This pattern explains why LH and FSH are not simply “two parallel hormones”, but components of a system in which the gonad sends return signals that remodel the gonadotropin profile in a function-specific manner.
The peripheral action of gonadotropins occurs through two distinct receptors, LHCGR (LH/hCG receptor) and FSHR, belonging to the family of G protein-coupled receptors. In the ovary, classical physiology is organized according to a principle of cellular cooperation: FSH acts primarily on granulosa cells, supporting follicular growth, differentiation and acquisition of functional competence, while LH acts primarily on theca cells, stimulating androgen steroidogenesis and, in advanced phases, contributing to follicular maturation, ovulation and luteal function. In parallel, granulosa cells can acquire LHCGR expression in the preovulatory phase, making the full response to the luteinizing signal possible and reorganizing the transcriptional program toward luteinization and progesterone production.
In the testis, LH and FSH exert complementary functions on different compartments: LH stimulates Leydig cells, promoting testosterone production through activation of steroidogenic programs, while FSH acts on Sertoli cells, supporting their role in spermatogenesis, the maturation of the tubular microenvironment and the production of regulatory signals that contribute to pituitary feedback. Here too, the general principle is that the gonadotropin is not a simple switch, but a signal that sets a functional direction and is “read” in the context of local cofactors, nutritional status and the systemic hormonal environment.
Signal transduction by gonadotropin receptors is dominated by the Gs pathway, with increased cAMP and activation of PKA, promoting rapid and transcriptional responses related to steroidogenesis, differentiation and functional maturation. However, LHCGR and FSHR can also activate additional pathways, including Gq branches, MAPK kinases, PI3K/AKT modulation and beta-arrestin-mediated pathways, contributing to “multichannel” signaling in which the final response depends on intensity, duration and cellular context. This concept is particularly important because structurally similar receptors can generate non-overlapping signaling profiles depending on the repertoire of coupling proteins and the differentiation state of the target cell.
A further level of regulation is the dynamics of desensitization, internalization and receptor recycling. Since gonadotropins act under physiological conditions that alternate phases of exposure with phases of signal reduction, the target cell must preserve sensitivity without undergoing inefficient chronic stimulation. Modulation of receptor density, regulation of signal termination systems and interaction with other hormones, such as insulin and thyroid hormones, contribute to the robustness of the system and explain why the same LH or FSH level may have different effects at different phases of the ovarian cycle or in different physiological states.
In summary, LH and FSH are the outputs of a neuroendocrine circuit that integrates hypothalamic pulsations, gonadal feedback and peripheral receptor capacity. Their physiology is a physiology of time and cooperation: between central and peripheral signals, between gonadal cellular compartments and between transduction pathways that transform an endocrine message into coordinated functional programs.
LH and FSH belong to the family of glycoprotein hormones together with TSH and hCG and share a common architectural principle: they are heterodimers composed of an identical alpha subunit (encoded by the CGA gene) and a specific beta subunit (encoded respectively by LHB and FSHB) that determines biological identity and receptor specificity. The two subunits associate non-covalently along the secretory pathway, and dimer stability, as well as the ability to activate the receptor, depends on correct maturation of both components and their conformational compatibility. Functionally, the beta subunit provides most of the surfaces that discriminate LHCGR and FSHR, while the alpha subunit contributes to formation of the active complex and to stability of the biologically effective particle.
Structurally, LH and FSH share with the other members of the family a fold dominated by the cystine knot motif, supported by disulfide bridges that define three-dimensional loops essential for maintaining binding geometry. A characteristic element of the beta subunits is the region often described as the “seatbelt”, a segment that partially wraps around the alpha subunit and helps limit dimer dissociation and stabilize the conformational arrangement necessary for receptor interaction. This clarifies a key point: the bioactivity of gonadotropins is not only “receptor recognition”, but the emergence of an architecture that must be correctly folded and assembled in order to expose binding surfaces effectively.
Synthesis occurs in gonadotroph cells as a multistep process. The alpha and beta subunits are translated as pre-proteins with a signal peptide and directed to the rough endoplasmic reticulum, where folding and formation of disulfide bridges begin under the control of chaperones and quality-control systems. Assembly of the heterodimer occurs early in the secretory pathway and represents a selective phase: subunits that have not matured correctly are retained and degraded, whereas suitable subunits proceed toward the Golgi apparatus. This step is decisive because it links molecular biology and physiology: the gonadotroph’s ability to produce competent gonadotropins depends both on transcription of the specific subunits and on the efficiency of maturation and assembly, which may vary in response to regulatory inputs of the axis.
The most relevant biochemical feature for function, pharmacokinetics and measurability is N-linked glycosylation. Gonadotropins have N-glycosylation sites on the alpha subunit and on the beta subunits, and the carbohydrate fraction introduces broad microheterogeneity of circulating isoforms with differences in branching, sialylation, fucosylation and sulfation. These variations are not neutral decorations: they modulate charge, stability and clearance rate, directly influencing the duration of biological action. A general principle is that more sialylated isoforms tend to have a longer half-life due to reduced hepatic removal, while less sialylated isoforms may show greater apparent activity in in vitro systems because of differences in interaction and microenvironment, creating a potential dissociation between potency measured in the laboratory and integrated efficacy in vivo.
For LH and FSH, the glycan signature also contributes to functional differences between apparently similar hormones. The same logic explains why hCG, although acting on LHCGR, has kinetic characteristics very different from LH because of specific glycosylation and overall structure. For pituitary gonadotropins, the gonadotroph cell can remodel the quality of the secreted forms in response to changes in steroid feedback and physiological context, modulating not only the quantity but also the “duration” of the peripheral signal through glycan composition. This makes glycosylation an integral part of the physiology of the axis.
A central biochemical issue concerns the relationship between immunoreactivity and bioactivity. Immunoassays measure epitopes that may depend on conformation and glycan microheterogeneity; therefore, different platforms may recognize specific populations of isoforms with different efficiencies. In selected scenarios, high-molecular-weight complexes analogous to the concept of macrohormone may also appear, such as macro-LH and macro-FSH, in which the hormone bound to immunoglobulins may be persistently elevated in tests despite reduced bioavailability. This is compounded by non-specific analytical interferences, such as heterophile antibodies and other interactions that can alter immunometric readings. Conceptually, these phenomena confirm that the “measured” object does not always coincide with the biologically active object, and that for gonadotropins molecular quality may become decisive for understanding laboratory-physiology discrepancies.
In terms of their circulating fate, LH and FSH have kinetics influenced by glycosylation, binding to plasma proteins and hepatic and renal clearance. Half-life and signal persistence are therefore emergent properties of protein structure and glycan signature, and translate into different tissue exposures for the same instantaneous pituitary secretion. In a system governed by GnRH pulses, this kinetic dimension is crucial: the same central pulsatility is “filtered” by the molecular properties of the hormone, determining how long the signal remains readable by the gonad between one pulse and the next.
In summary, LH and FSH are hormones whose biochemistry is already physiology. Alpha-beta heterodimerization, the cystine knot fold, seatbelt-type stabilization and, above all, glycosylation microheterogeneity define the stability, duration and measurability of the signal. Through transcriptional control of the subunits and regulation of post-translational maturation, the gonadotroph cell modulates not only how much hormone is secreted, but also which set of isoforms contributes to the endocrine message that governs reproductive function.
The secretion of LH and FSH is a dynamic process in which the value measured in a single blood sample reflects the momentary result of overlapping temporal components, dominated by GnRH pulsatility and modulated by gonadal feedback acting over minutes, hours and days. LH and FSH are produced by the same pituitary cell population, the gonadotroph, but they do not behave as two “copies” of the same signal: they share the common alpha subunit of glycoprotein hormones, while having specific beta subunits and, above all, responding differently to the frequency of the hypothalamic drive and to intrapituitary regulators of the transcriptional program. This architecture allows the hypothalamic-pituitary-gonadal axis to generate an output that is simultaneously coordinated and differentiated, capable of supporting steroidogenesis, gametogenesis and follicular maturation or spermatogenesis in parallel.
On an ultradian scale, LH and FSH show pulsatile secretion that mirrors, with transformations specific to the gonadotroph, the pattern of GnRH releases into the portal circulation. In males, the system is organized to provide a relatively stable pulsatile tonic drive, maintaining stimulation of Leydig cells and Sertoli cells in a manner consistent with continuous androgen production and support for spermatogenesis. In females, pulsatility is more variable because the pulse generator is cyclically modulated by ovarian steroids: the system changes the frequency and amplitude of bursts to modify the functional LH FSH ratio in the different phases of the cycle, making follicular selection, final maturation and preparation for ovulation possible.
The differentiation between LH and FSH emerges particularly clearly when considering the relationship between frequency of GnRH pulses and the gonadotroph response. In general, closer pulses tend to favor LH production and secretion, while more widely spaced pulses make FSH output relatively more efficient, not because the cell “chooses” one hormone in a binary manner, but because frequency decoding produces different signaling and transcriptional programs, with different kinetics for beta subunit genes. This principle of “temporal coding” is essential for understanding how the axis can rapidly remodel its endocrine signature without requiring major variations in the total amount of GnRH released.
Alongside the release pattern, a relevant proportion of the difference between LH and FSH is determined by secretion biology and by the pharmacokinetics of the two gonadotropins. Both are glycoprotein hormones, and glycosylation heterogeneity influences stability, clearance and biological activity. In physiology, FSH tends to have a longer circulating persistence than LH, partly because of glycosylation features that may increase sialylation and reduce clearance, while LH has a more rapid profile and is more closely linked to bursts. This means that, for the same secretory variability, FSH appears more “integrated” over time and LH more “pulsatile”, contributing to the different interpretation of the signal in relation to blood sampling timing.
In females, there is also a unique temporal phenomenon, the preovulatory LH surge. In that context, the axis shifts from a pulsatile regime to a prolonged secretion regime culminating in an LH peak that is essential for triggering ovulation and luteinization. This event should not be understood as a simple quantitative amplification, but as a change in the operating mode of the circuit, made possible by the transition from negative feedback to positive estrogen feedback on specific hypothalamic networks. FSH may show an associated increase, but remains more constrained by intrapituitary regulation and inhibin feedback, maintaining a distinct signature even during the phase of maximal reproductive drive.
The hypothalamic regulation of LH and FSH is governed by GnRH, the signal that translates the activity of central reproductive networks into stimulation of the pituitary gonadotroph. GnRH does not act as a tonic stimulus, but as an intermittent signal, because the gonadotroph is built to decode the frequency of pulses. This dependence is a biological requirement: continuous stimulation of the GnRH receptor leads to loss of signal efficacy, whereas the pulsatile pattern preserves the response and allows selective modulation of the synthesis of the LH and FSH beta subunits.
The central generator of pulsatility depends on hypothalamic networks in which kisspeptinergic neurons play a key role, as they can potently activate GnRH neurons and integrate gonadal feedback and metabolic signals. In physiological regulation, kisspeptin functions as a node that transforms information on sex steroids into changes in the GnRH pattern: under negative feedback conditions it supports a pulsatile regime compatible with folliculogenesis and steroidogenesis, whereas under positive feedback conditions, especially in females, it contributes to the transition toward the arrangement that enables surge generation. The hypothalamic network does not work in isolation: circadian signals, energy status, stress and arousal modulate the probability of GnRH neuron activation and therefore the temporal structure of gonadotropin output.
At the pituitary level, GnRH binds to the specific receptor of the gonadotroph, a seven-transmembrane-domain receptor that predominantly activates pathways coupled to Gq/11. This results in a phospholipase cascade, production of IP3 and DAG, calcium mobilization and activation of kinases such as PKC and MAPK pathways, converging on two functions: exocytosis of granules containing LH and FSH and transcriptional regulation of subunit genes. The crucial point is that these pathways have different kinetics and show different desensitization and recovery; consequently, rapid or slow GnRH pulses do not simply produce more or less “secretion”, but change how the cell distributes resources between synthesis of LH beta and FSH beta, reorganizing endocrine output over time.
Hypothalamic regulation, however, is not sufficient to explain FSH physiology. FSH is strongly influenced by local and systemic regulators that act mainly on its synthesis, making it a hormone in which the GnRH drive is necessary but not exclusive. In particular, the interaction between hypothalamic stimulus and the pituitary microenvironment allows fine modulation of the LH FSH ratio in response to precise reproductive requirements. This explains why the axis can produce, for the same global GnRH secretion, a more luteinizing or more follicle-stimulating output, depending on the hormonal context and the regulatory network converging on the gonadotroph.
In females, the distinction between pulsatile regime and surge is a paradigmatic example of qualitative hypothalamic control. The surge derives from a change in network state, in which the sustained increase in preovulatory estrogens modifies the activation mode of the neurons governing GnRH and kisspeptin, producing a more continuous and prolonged signal. The gonadotroph interprets this signal through massive LH secretion, demonstrating that the hypothalamus regulates not only how much hormone is released, but also the temporal how of the signal that determines a distinct biological response.
Gonadal feedback gives the hypothalamic-pituitary-gonadal axis the ability to maintain functional stability despite pulsatile output and continuous environmental and behavioral changes. The key principle is that hormones produced by the gonads, particularly estradiol, progesterone and testosterone, modulate GnRH release and pituitary responsiveness upstream, regulating both the intensity and the temporal structure of LH and FSH secretion. Under basal conditions, negative feedback maintains the axis in a regime that supports reproductive function without excessive stimulation; in females, the possibility of switching to positive estrogen feedback in a specific window of the cycle enables the ovulatory event, demonstrating that feedback can physiologically change its sign.
A distinctive element of FSH control is the presence of not only steroid feedback but also peptide feedback, mediated by the inhibin, activin family and their binding antagonist follistatin. In physiology, activin produced locally and in gonadal sites can increase FSH beta synthesis through signaling pathways that converge on transcriptional mediators of the SMAD family, whereas inhibin, produced mainly by the gonads, attenuates this drive and selectively reduces FSH production. Follistatin neutralizes activin by binding it and reducing its bioavailability, adding a further level of intrapituitary control. This circuit explains why FSH is often the hormone most sensitive to subtle changes in follicular or Sertoli function and why its profile can be modulated selectively compared with LH.
The notion of an individual set point of the reproductive axis arises from the fact that each subject tends to maintain a relatively stable relationship between GnRH pattern, mean LH and FSH levels and gonadal output, but this relationship depends on multiple biological determinants. These include the sensitivity of hypothalamic circuits to sex steroids, the efficiency of GnRH receptor signal transduction in the gonadotroph, pituitary secretory capacity, the state of the activin inhibin follistatin circuit and peripheral variables such as clearance, glycosylation and receptor availability in target tissues. For this reason, the population reference interval does not necessarily coincide with the optimal range for the individual, and intraindividual consistency over time may be high if contextual conditions remain similar.
Feedback operates over different time scales. There is a rapid component, which modulates the probability of bursts and the gonadotroph response to GnRH over minutes and hours, and a slow component, which acts on gene transcription, receptor expression and plasticity of the hypothalamic and pituitary circuit. In females, this temporal stratification is fundamental for cyclicity: progressive modulation of pulse frequency, together with changes in inhibin and activin, enables dominant follicle selection, the preovulatory rise in estrogens and the transition to the surge; in males, the balance between androgens and Sertoli signals helps stabilize secretion in a pulsatile regime that ensures functional continuity.
Understanding feedback and set point in the LH FSH axis therefore means recognizing that gonadotropins are not simple “values”, but informational signals over time, shaped by GnRH frequency coding, selective regulation of FSH through inhibin activin follistatin and steroid feedbacks that can stabilize or, in specific physiological conditions, radically transform the operating mode of the circuit. This perspective is essential for distinguishing physiological variability from pathological disorganization and for correctly interpreting isolated measurements in relation to the subject’s temporal and biological context.
The pituitary gonadotropins LH and FSH belong to the family of glycoprotein hormones and share a common alpha subunit, while biological specificity is determined by the beta subunit. This architecture is reflected in the structure of their respective receptors, LHCGR (LH and hCG receptor) and FSHR, which are membrane receptors of the GPCR family for glycoprotein hormones with a large extracellular domain. Both possess a large N-terminal extracellular domain rich in leucine-rich repeats, a hinge region that acts as a mechanical transducer between ligand binding and activation of the receptor core, and a seven-helix transmembrane domain responsible for G protein coupling and activation of intracellular cascades. The hinge region and specific glycosylation features of both ligand and receptor contribute to the stabilization of different conformational states, making “selective” signaling plausible, in which different ligands or different conditions may favor specific branches of transduction.
The central principle of LHCGR and FSHR activation is that hormone binding does not determine a simple on-off state, but a continuum of conformations. The arrangement of the seven-helix core, the relative position of the hinge region and the dynamics of extracellular loops modulate coupling efficiency to different G proteins and engagement of regulatory systems such as beta-arrestins. This property is crucial in reproductive physiology, because the target cell must integrate pulsatile and cyclic hormonal signals with local signals from the ovarian or testicular microenvironment, maintaining sensitivity and preventing saturation of the system in the presence of prolonged stimuli.
Functionally, both FSHR and LHCGR predominantly activate the Gs pathway, with increased cAMP, activation of PKA and regulation of cytosolic and nuclear targets. In granulosa and Sertoli cells, this branch drives programs of differentiation and gametogenic support, while in Leydig cells and ovarian theca cells it sustains steroidogenesis and the enzymatic activity required for the production of androgens and, indirectly, estrogens. The cAMP PKA signal is not uniform within the cell space, but organized into microdomains regulated by scaffolds and phosphodiesterases, allowing rapid responses on trafficking and phosphorylation and slow responses on transcription without loss of control and without indiscriminate activation of the entire cytosol.
Alongside the Gs pathway, activation may also involve the Gq/11 pathway, with activation of phospholipase C, production of IP3 and DAG, increased intracellular calcium and activation of PKC. The relative contribution of this branch depends on cell type, stimulus intensity and pattern and the maturation state of the target cell. In reproductive contexts, the calcium-dependent component becomes particularly important when the response requires a rapid change in functional state, such as follicular transition toward ovulatory competence or intensive activation of steroidogenesis under conditions of high demand.
Downstream of Gs and Gq, LHCGR and FSHR converge on integration pathways that include MAP kinases such as ERK and p38 and growth and survival pathways such as PI3K AKT. These circuits mediate effects on proliferation, cytoskeletal remodeling, protein synthesis and resistance to stress, and explain why gonadotropins are not only “switches” for steroid production or gametogenesis, but also trophic signals capable of modulating follicular growth, differentiation of support cells and functional stability of the gonadal microenvironment. An increasingly relevant aspect is the engagement of beta-arrestin-mediated modules and the possibility of signaling from endosomal compartments after internalization, with cAMP production or ERK activation in a spatially compartmentalized manner. This organization makes it possible to distinguish signaling branches of different duration and to connect receptor trafficking dynamics to the quality of biological output.
The receptor response is subject to desensitization and dynamic regulation through receptor phosphorylation, beta-arrestin recruitment, internalization and recycling or degradation. These mechanisms are fundamental because the reproductive axis works with pulsatile and cyclic stimuli, and the cell must retain the ability to discriminate changes in signal over time. In parallel, the presence of ligand heterogeneity and glycosylation variability may modulate the efficacy and relative direction of signaling branches, contributing to the physiological plasticity of the gonadotropin system.
Finally, LH and FSH receptors should be considered network nodes that integrate endocrine signals with local paracrine signals. In the ovarian follicle, factors such as IGF, members of the TGF beta family, cytokines and oocyte-derived signals modulate the competence of somatic cells to respond to gonadotropins, amplifying or attenuating specific signaling branches. In the testis, local signals among Sertoli cells, Leydig cells and the germinal compartment help determine whether gonadotropin stimulation translates mainly into steroidogenesis, gametogenic support or structural remodeling. In this perspective, FSHR and LHCGR are not simple sensors, but contextual transducers capable of generating different outputs with the same ligand depending on the microenvironment.
The biological effects of LH and FSH are organized as a coordinated program that supports gametogenesis, steroidogenesis and reproductive cyclicity. The functional logic is one of cooperation: FSH tends to promote growth and differentiation of support cells and the preparation of the gonadal compartment for the steroid response, whereas LH acts as a key signal for steroid production and for rapid transition events, such as ovulation and luteinization in females, or acute stimulation of steroidogenesis in males. This complementarity allows fine and phase-dependent control, in which the body modulates reproduction according to age, energy status and peripheral feedback signals.
In the ovary, the primary target of FSH is the granulosa cell. FSH promotes follicular growth, proliferation and functional differentiation, supporting the expression of enzymes and proteins necessary for follicle maturation. A central node is the induction of aromatase and components of steroidogenesis in granulosa cells, allowing conversion of androgens produced by the theca into estrogens according to the cooperative two-cell, two-gonadotropin model. In parallel, FSH promotes the production of mediators such as inhibin, which participates in selective feedback on FSH at the pituitary level, and modulates factors that influence the quality of the follicular microenvironment. A key step in follicular physiology is the acquisition of LH receptors by granulosa cells in advanced phases: this transition, substantially supported by FSH, makes the follicle competent to respond to the ovulatory signal and to move toward luteinization.
The main target of ovarian LH includes the theca cells and, in advanced phases, luteinized granulosa cells. In the theca, LH stimulates androgen production through activation of steroidogenic enzymes and increased availability of substrates and mitochondrial transporters involved in steroid synthesis. These androgens constitute the substrate for aromatization in granulosa cells, making LH indispensable for overall estrogen production even though it acts on a different cell. In the periovulatory period, the LH signal triggers the cascade that culminates in ovulation, with rapid follicular changes that include matrix remodeling, modulation of physiological inflammatory mediators and transformation of granulosa cells into luteal cells capable of producing progesterone. Maintenance of the corpus luteum and progestin production in the luteal phase depend on the persistence of adequate LH drive, which supports steroid function and the structural stability of luteal tissue.
In males, LH acts primarily on Leydig cells, stimulating the synthesis of testosterone. Locally produced testosterone is essential for spermatogenesis and for the maintenance of secondary sexual characteristics, and acts both paracrinely and systemically. Activation of LHCGR in Leydig cells increases cholesterol availability and flux through the enzymatic steps of steroidogenesis, transforming a pulsatile pituitary signal into steroid production that can be rapidly modulated and stabilized over time. FSH, instead, acts mainly on Sertoli cells, supporting the microenvironment required for germ cell maturation. FSH promotes the supportive function of Sertoli cells, the production of growth factors and transport proteins and contributes to the regulation of inhibin B, which represents an important feedback signal for the selective control of FSH at the pituitary level. Physiological spermatogenesis therefore emerges from the integration between LH-dependent Leydig testosterone and FSH-dependent Sertoli support, with local interactions making the final output sensitive to variations in both signals.
The effects of LH and FSH are not limited to the gonads as individual organs, but are reflected throughout the body through the production of sex steroids and the organization of the reproductive cycle. Estrogens, progesterone and testosterone modulate bone, metabolism, the cardiovascular system, skin, muscle and neurobehavioral function, and these actions are indirectly dependent on correct gonadotropin dynamics. In parallel, gonadotropins participate in the construction of feedback loops that stabilize the axis: estradiol and progesterone modulate the frequency and amplitude of the hypothalamic drive and pituitary response, while inhibin, activin and follistatin more selectively regulate the synthesis and secretion of FSH. This stratification of feedback enables fine control in which LH and FSH can vary differentially, maintaining functional coherence with the phase of the cycle or reproductive state.
The physiology of LH and FSH is dominated by the principle that endocrine information from the reproductive axis is encoded over time. Gonadotropin secretion is driven by hypothalamic GnRH pulsation, which represents the primary neural determinant of pulsatile pituitary release. This pattern is not an accessory detail: pulsatile stimulation is required to maintain competence and responsiveness of gonadotroph cells, whereas continuous stimulation tends to reduce secretion through mechanisms of receptor desensitization and remodeling of transduction. The frequency and amplitude of GnRH pulsations, and therefore of LH and partly of FSH, change according to sex, age and phase of the menstrual cycle, generating temporal profiles with precise physiological meaning.
On an ultradian scale, LH is typically the most markedly pulsatile signal and tends to reflect the frequency of GnRH pulses more faithfully. FSH, although also influenced by pulsatility, often appears more “integrated” over time, because its dynamics are strongly modulated by intrapituitary and gonadal regulators such as activin, inhibin and follistatin, and because differences in half-life and clearance help smooth instantaneous variability. In physiology, this results in a situation in which two closely spaced blood samples may show significant differences, especially for LH, even in the absence of a true change in the state of the axis. Intraday variability is therefore an expected property of a pulsatile system and not random biological noise.
The chronobiology of gonadotropins also includes a circadian and sleep-related dimension, particularly evident in specific phases of life. During puberty, the nocturnal increase in pulsatile GnRH and LH secretion is a characteristic phenomenon: sleep, and especially its architecture with deep phases, acts as a physiological window that amplifies pulsation and contributes to pubertal progression. Sleep-wake sensitivity may change during development, with a transition from strongly nocturnal profiles in the early phases to a more uniform distribution between night and day as the axis matures. In adults as well, sleep changes and sleep fragmentation may influence pulsatile dynamics, in keeping with the integrative nature of hypothalamic control.
In women of reproductive age, LH and FSH variability takes on a cyclic structure. During the early follicular phase, relatively higher FSH levels support follicular recruitment, while the progressive increase in estradiol and inhibin contributes to dominant follicle selection and modulation of the FSH profile. The periovulatory phase is characterized by the LH surge, a critical temporal event that triggers oocyte maturation, ovulation and luteinization, and emerges from the transition of estrogen feedback toward a positive mode in a permissive context of the axis. In the luteal phase, progesterone and other signals modulate pulsatile frequency and contribute to a different secretory arrangement, consistent with maintenance of the corpus luteum and endometrial preparation. This cyclicity makes it evident that speaking of a “normal value” without reference to cycle phase means ignoring the temporal language of the axis.
In adult males, pulsatile LH secretion dynamically drives testicular testosterone production and contributes to maintaining steroid levels that, although relatively stable on average, are sustained by intermittent pulses. Here too, variability between closely spaced measurements is physiological and depends on the phase of the pulsatile cycle. In both sexes, with aging and changes in gonadal status, the feedback arrangement changes, and this is reflected in gonadotropin levels and variability, with a relevant interindividual component related to the set point of the axis and the sensitivity of feedback circuits.
A further level of variability derives from the fact that the reproductive axis integrates energy and stress signals. Caloric restriction, intense exercise, rapid changes in energy balance and acute or chronic stress can modulate the pulsatile dynamics of the hypothalamic drive and therefore LH and FSH secretion, with effects that have adaptive significance in human physiology. Overall, LH and FSH must be interpreted as temporal signals: their variability reflects a pulsatile control system, modulated by steroid feedback and by selective regulators of FSH synthesis, and organized on ultradian, circadian and cyclic scales.
The physiology of the pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), changes substantially throughout life because the hypothalamic-pituitary-gonadal axis must alternate between different functional modes: fetal and neonatal organization, relative quiescence of childhood, pubertal reactivation, reproductive cyclicity, menopausal transition and aging-related remodeling. LH and FSH share the same cell of origin, the gonadotroph, and a common molecular pattern as heterodimeric glycoproteins with a shared alpha subunit and specific beta subunits; however, their secretion and physiological meaning diverge because the network that governs them integrates at least three levels of control: pulsatility of hypothalamic GnRH, gonadal steroid and peptide feedbacks (inhibins, activins, follistatin) and central modulation by metabolic, circadian and neurovegetative signals. In this arrangement, age modifies not only “how much” LH and FSH are secreted, but above all the probability that a given temporal pattern and a given feedback sensitivity will become dominant.
In the neonatal period, the most characteristic physiological event is the transient reactivation of the gonadotropic axis after birth, commonly described as mini-puberty. Following removal of placental inhibition and rapid reorganization of central feedbacks, an increase in LH and FSH is observed, reaching peak values in the first months of life, with different timing and proportions in boys and girls. In males, the relative increase in LH is often more marked and supports testicular stimulation, whereas in females the FSH component may be relatively more prominent and more prolonged, in parallel with the dynamics of the early ovarian compartment. The physiological meaning of this phase is not immediately “reproductive”, but organizational: it provides a temporary endocrine drive that contributes to the maturation of gonads, endocrine pathways and target receptors, and makes it clear that the gonadotropic system is already competent very early, but is then physiologically silenced by the organization of feedbacks and central control during childhood.
During childhood, the axis enters a phase of relative quiescence, in which LH and FSH are generally low and hypothalamic pulsatility is attenuated. This reduction does not imply absence of function, but a neuroendocrine arrangement in which the network is maintained in a state of “readiness” with minimal output. Physiologically, childhood is the period in which the integration circuits among energy signals, sleep and neurotransmitters are consolidated and will later help make pubertal reactivation possible. The consequence is that small contextual variations can produce measurable oscillations without this necessarily being equivalent to a stable change in the set point, especially if samples are not standardized in time and biological context.
Puberty represents the physiological reactivation of the axis and depends on the progressive increase in the frequency and amplitude of GnRH pulsations, with a consequent increase in LH and FSH. The transition does not occur as a simple linear increase, but as a dynamic reorganization of the signal: gonadotropin bursts become more evident, initially with greater nocturnal expression and then with progressive extension to the daytime period. In this phase, a key principle of gonadotroph physiology emerges: the frequency of GnRH pulsations can differentially favor LH synthesis and secretion over FSH, while gonadal peptides, especially inhibins and activins, act as selective regulators of the FSH branch. Puberty, therefore, is not only “more gonadotropins”, but a new regime of information coding that allows the gonads to produce steroids and gametes in a manner consistent with somatic and neurobehavioral maturation.
In female reproductive age, LH and FSH acquire an eminently cyclic physiology, governed by interaction between the gonadotroph and the ovary. FSH tends to support follicular growth and the aromatase competence of the follicle, while LH supports theca steroidogenesis and, in the late follicular phase, final maturation and ovulation through an amplification event known as the LH surge. This peak is not a simple “increase”, but the result of a temporary reconfiguration of estrogen feedback from negative to positive at the hypothalamic-pituitary level, made possible by the neuroendocrine context of the late follicular phase. In the luteal phase, the arrangement is reversed: progesterone and estrogens restore predominantly negative feedback and reorganize pulsatility, reducing the likelihood of new surges and stabilizing a profile more consistent with support of the corpus luteum. In this architecture, LH and FSH cannot be interpreted as “static” values because their physiological meaning depends on the phase of the cycle and on the temporal profile of the signal.
In adult males, LH and FSH operate in a more stationary regime, but not one devoid of dynamics. LH stimulates Leydig cells and supports testosterone production, while FSH acts mainly on Sertoli cells and contributes to the regulation of spermatogenesis, in close integration with local signals and with feedback exerted by inhibin B. In men too, secretion is pulsatile and reflects GnRH pulsatility; however, the absence of ovarian cyclicity makes the profile more “continuous” over time, while preserving intraindividual variability related to sleep, stress, energy status and circadian rhythms.
With the menopausal transition and menopause, female gonadotropin physiology changes markedly because the negative feedback exerted by follicles and ovarian steroids progressively decreases. The most characteristic consequence is the increase in FSH, often earlier and more pronounced, while LH also tends to increase. The central physiological point is not only the rise in values, but the reorganization of the control system: the same hypothalamic-pituitary network now operates with different peripheral signals and with a new balance between central drive and residual feedback. Variability also increases in this phase, because residual follicular activity may be intermittent and the system may oscillate between transient states before stabilizing in the postmenopausal regime.
In male aging, changes in gonadotropins depend on the balance between testicular steroid production, tissue sensitivity and feedback integrity. On average, variations in gonadal function and in the response of central circuits may modify LH and FSH, but the direction and magnitude of the change are not uniform because comorbidities, changes in fat mass, medications and sleep modifications intervene. Physiologically, age tends to increase the complexity of the context, making it more likely to observe gonadotropin profiles that reflect the integration of multiple determinants rather than a single driver.
Overall, LH and FSH describe a physiological trajectory in which the axis is transiently active during mini-puberty, relatively silent in childhood, reactivated in puberty, cyclic in women of reproductive age, more stationary but pulsatile in adult men and profoundly remodeled during the menopausal transition and aging. This natural history emphasizes one principle: the meaning of LH and FSH is not contained in the number itself, but in the biological time and feedback context in which that number is generated.
Measurement of LH and FSH is based mainly on automated immunoassays, largely in a two-site immunometric format (sandwich), in which a capture antibody and a detection antibody recognize distinct epitopes of the molecule and generate a signal proportional to the amount of complex formed. This architecture ensures high sensitivity and throughput, but defines an essential metrological principle: the measurement does not quantify “gonadotrophic function” or “bioactivity”, but rather a fraction of immunoreactivity determined by the combination of antibodies, signal chemistry and calibration. For this reason, analytical quality depends not only on the limit of quantification, but also on robustness toward molecular variants and interferences, calibration stability and management of the preanalytical phase.
A cornerstone of laboratory principles is standardization and traceability to international standards. For LH and FSH, reference materials have been established and updated over time by international organizations, including World Health Organization standards and materials distributed by reference institutes, used to calibrate bioassays and immunoassays and to reduce intermethod variability. However, standardization, while necessary, does not completely eliminate differences because reference materials may not be fully commutable with native human serum across all platforms. The practical consequence is that intermethod comparability remains limited, especially when comparing results obtained with different analytical systems or after platform changes over time.
The deeper reason for this incomplete commutability lies in the molecular nature of gonadotropins. LH and FSH are glycoproteins with relevant microheterogeneity due to glycosylation, which modifies charge, half-life, receptor affinity and, in part, antibody recognition. The circulating population includes isoforms with different contents of terminal residues and differences in sialylation and sulfation, with variations that may depend on age, sex, phase of the cycle and endocrine context. In an immunoassay, different antibodies may have different sensitivity toward specific isoforms, and this may produce discrepancies between platforms even when the overall biological meaning of the sample is similar. This leads to an operational principle: the LH or FSH result is partly method-dependent because it reflects a specific window of immunoreactivity rather than the totality of circulating forms weighted identically.
A further level of complexity derives from the fact that immunometric measurement does not necessarily coincide with bioactivity. Gonadotropins exert their effect through specific receptors and intracellular signaling, and biological potency may vary with isoform composition. Calibrator materials and native samples may differ in isoform and matrix composition, and this may alter the relationship between immunometric signal and receptor activation capacity. This does not make the immunoassay unreliable, but requires it to be considered a measurement system with specific properties, not a universal thermometer of gonadotrophic function.
The preanalytical phase has substantial weight because LH and FSH are secreted in a pulsatile manner and are influenced by chronobiology and context. For LH in particular, pulsatility tends to be more evident and may determine marked variations even over short time scales, while FSH, although pulsatile, often has relatively more attenuated intradiel variability thanks to a longer half-life and additive regulation by gonadal peptides. Time of blood sampling, sleep, acute stress, exercise and nutritional status can influence the result, and in women the dominant element is the phase of the cycle, which determines broad physiological differences. These factors are compounded by common technical elements: matrix type, separation times, sample stability, storage and freeze-thaw cycles. In longitudinal comparisons, standardization of the context is an integral part of the laboratory principle because it reduces variability not related to the analytical system.
Immunochemical interferences are a mandatory chapter. Heterophile and anti-species antibodies may produce spurious signals in sandwich tests by creating bridges between the capture antibody and the detection antibody, causing false increases, or by interfering with binding and generating underestimates. Autoantibodies and antibodies directed against components of the detection system may alter the reading in variable directions. In systems based on biotin streptavidin, biotin intake may disturb anchoring and separation steps and distort the result depending on test architecture. These phenomena remind us that the numerical datum is the product of an immunochemical chain that may be perturbed even when the true concentration of the analyte does not change.
A further analytical limitation of immunometric systems is the high-concentration effect, known as the hook effect in some architectures, in which an excess of analyte prevents correct formation of the sandwich complex and produces falsely low results. The mechanism is linked to independent saturation of antibody sites and loss of cross-linking capacity, with distortion of the response curve. This phenomenon is not the rule in routine practice, but represents an intrinsic limitation of immunometric models when the linearity range is exceeded, and makes control strategies such as dilutions and consistency checks important in samples with suspected very high concentrations.
In summary, LH and FSH measurement is an achievement of modern clinical chemistry, but its meaning depends on traceability to international standards with imperfect commutability, on glycosylation microheterogeneity that makes the signal partly method-dependent, on preanalytical control and on robustness against interferences and high-concentration phenomena. The final measurement is therefore informative when read as the output of a well-characterized measurement system, not as an absolute property of the sample independent of method.
LH and FSH are often treated as “indicators” of gonadal function, but from a physiological perspective they are more accurately described as integrated signals produced by a control network that encodes information over time. Their circulating concentration is not the direct measure of gonadal output, but the output of a regulator that integrates hypothalamic GnRH pulsatility, steroid feedback, selective peptide feedback and central modulation by sleep, stress and metabolic signals. An isolated value therefore cannot capture the multidimensionality of the network or distinguish between stable equilibrium and a transient state.
A first conceptual limit is pulsatility. LH secretion, in particular, occurs in bursts that may determine large variations over short periods; a single sample may therefore reflect the phase of the burst more than the state of the set point. FSH tends to have smoother dynamics, but remains influenced by temporality because it is the product of a combination of GnRH drive and selective regulation by inhibins and activins. For this reason, LH and FSH, observed only once, sample a point on a dynamic curve and may lose much of the information that resides in the frequency and temporal distribution of the signal.
A second limit is dependence on biological context, especially in women. The physiological meaning of LH and FSH changes with the phase of the ovarian cycle because feedbacks change and the operating mode of the network changes. A value that is fully physiological in one phase may be uninterpretable in another if read without context. The most emblematic case is the LH surge, which represents a temporary reconfiguration of estrogen feedback and not a simple quantitative increase; an isolated sample that does or does not intercept this event may be radically different without this corresponding to a difference in the “state” of the axis, but only to a temporal difference.
A third limit is nonlinearity and feedback specificity. LH and FSH do not respond identically to the same signals: the frequency of GnRH pulsations may differentially favor synthesis of the beta subunits and therefore relative production of the two hormones, while inhibin B and activins selectively modulate the FSH branch. As a result, the same peripheral condition may be translated into different combinations of LH and FSH depending on the pulsatile regime and the sensitivity of the system at that moment. The isolated value does not contain information on the frequency of the GnRH drive or on the peptide component of feedback, and therefore does not allow univocal inference of the “causal direction” of the observed variation.
A fourth limit concerns biological individuality. Personal set points exist, determined by hypothalamic-pituitary sensitivity, gonadal receptor status and feedback intensity. Interindividual variability may be broad, while intraindividual repeatability may be greater if the sampling context is comparable. This means that a value within the population range may represent a significant deviation from the individual baseline, or the opposite. LH and FSH are therefore more informative when observed longitudinally and in context, compared with when they are read as decontextualized numbers.
A fifth conceptual limit is that LH and FSH mainly describe the state of the hypothalamic-pituitary circuit and its dialogue with the gonad, not necessarily the final peripheral effect in target tissues. In males, for example, LH is linked to steroidogenesis, but the final biological effect also depends on substrate availability, receptor sensitivity and peripheral conversions. In women, FSH supports follicular growth, but ovarian response depends on the available follicular cohort and tissue competence. This makes LH and FSH powerful indicators of central regulation and gonadal feedback, but not direct measures of peripheral tissue function, which is the result of multiple downstream steps.
Finally, there is an epistemological limit linked to the fact that LH and FSH are numbers obtained through immunoassays that measure immunoreactivity and are affected by glycosylation microheterogeneity, incomplete commutability of calibrators and immunochemical interferences. Even with excellent methods, the reported value may be influenced by the method and analytical context, and in particular conditions may deviate from the biological signal that one would like to describe. Taken together, these limits show that LH and FSH are not absolute sensors of the gonad, but the numerical representation of dynamic signals generated by a network. Their maximum informational value emerges when they are placed in biological time, reproductive phase and the context of feedback and method, rather than when they are treated as isolated and atemporal indicators.